1. Insulin elicits the activation of two distinct membrane-bound cyclic AMP phosphodiesterases when incubated at 37°C for 5min with intact hepatocytes: the 'dense-vesicle' enzyme and the peripheral-plasma-membrane enzyme. 2. In hepatocytes the lysosomotropic agents chloroquine, methylamine and NH4Cl, as well as intracellular ATP depletion elicited by fructose or incubation with insulin at 220C, blocks selectively the activation of the 'dense-vesicle' enzyme. 3. Incubation of hepatocytes with bacitracin, leupeptin and a variety of proteinase inhibitors failed to affect insulin's activation of these two cyclic AMP phosphodiesterases by distinct routes. It is suggested that activation of the 'dense-vesicle' enzyme occurs through a pathway triggered by the endocytosis, processing and recycling of the insulin receptor. This might involve the delivery, with subsequent activation, of a latent phosphodiesterase into this fraction.
Although over the past few years there have been significant advances in our understanding of the structure of the insulin receptor (see, e.g., Czech, 1981) , the molecular events that occur immediately upon occupancy of the receptor by insulin are ill-understood (see, e.g., Czech, 1977; Houslay, 1981; Denton et al., 1981) . More recently, however, evidence has been provided to suggest two molecular mechanisms whereby insulin might initiate events at the plasma membrane that could affect intracellular processes. The first is the observation that the insulin receptor itself is a protein kinase (Kasuga et al., 1981) . This kinase activity is highly unusual in that it specifically transfers phosphate groups to tyrosine residues on target proteins and also autophosphorylates the insulin receptor. In this respect it bears great resemblance to the epidermal-growth-factor receptor and to the kinase gene products of transforming viruses, such as pp6Osrc from Rous sarcoma virus (see Houslay, 1981) . This might imply that such an activity reflects the long-term growth-promoting properties of insulin. Secondly, evidence has been presented (Heyworth et al., 1983a,b; Heyworth & Houslay, 1983) which suggests that insulin exerts effects through a specific type of guanine nucleotide regulatory protein and associated protein kinases. This regulatory protein has been demonstrated to mediate insulin's activation of a plasma-membrane cyclic AMP phosphodiesterase and inhibition of adenylate cyclase. The activation of membrane-bound kinases is undoubtedly a credible mechanism for initiating a variety of intracellular events (see Denton et al., 198 1; Houslay, 198 1; Cohen 1982) . However, upon occupancy by insulin the receptor is rapidly internalized into the cell (see, e.g., Fehlmann et al., 1982) , which might provide a further route by which insulin could initiate intracellular processes.
In hepatocytes there are two distinct cyclic AMP phosphodiesterases which are activated by insulin . The first is a plasmamembrane enzyme, which is activated through a phosphorylation mechanism (Marchmont & Houslay, 1980b; Houslay et al., 1983a,b) mediated by a specific guanine nucleotide regulatory protein and associated protein kinase (Heyworth et al., 1983a, b) . The second is the 'dense-vesicle' enzyme, which is associated with a unique intracellular vesicle fraction, resolved by us on Percoll gradients. This enzyme does not appear to be activated by insulin through a route involving the proposed guanine nucleotide regulatory protein . Here we provide further evidence to show that insulin's activation of these enzymes is achieved by distinct routes.
Materials and methods
All methods, including the preparation of hepatocytes, incubation conditions for hepatocytes, Percoll fractionation of a hepatocyte homogenate, assay of cyclic AMP phosphodiesterase and determinaVol. 216 tion of intracellular ATP content, were performed precisely as described in some detail by .
In some experiments the 'dense-vesicle' phosphodiesterase that is activated by insulin (Heyworth et al., 1 983a) was selectively solubilized from a hepatocyte homogenate by the procedure characterized and developed by Loten et al. (1978) . Briefly, this involved homogenizing, at 40C, hepatocytes in 0.25 M-sucrose/2 mM-EDTA/20 mM-Tris/HCl, final pH7.4, with 30 strokes of a ground-glass homogenizer. A particulate fraction was obtained by centrifugation at 20000ggav for 20min. This fraction was extracted with 1 mM-EDTA/20mM-Tris/HCI, final pH 7.4, with four strokes of the homogenizer before centrifugation as above to yield a supernatant, which was used for phosphodiesterase assay.
This hypo-osmotic-shock procedure has been demonstrated to release selectively a single insulin-activated phosphodiesterase (Loten et al., 1978) , whose properties and conditions of activation define it as being the 'dense-vesicle' enzyme (see Heyworth et al., 1983a , for discussion).
Results
Treatment of hepatocytes with lOnM-insulin for 5min led to the activation of two distinct, membrane-bound, cyclic AMP phosphodiesterases, namely the 'dense-vesicle' enzyme and the plasmamembrane enzyme . The activation of these enzymes was assessed from Percoll gradients of hepatocyte homogenates (Table  1) . A similar activation of the 'dense-vesicle' enzyme was also observed (Table 1) when followed by a hypo-osmotic-shock procedure (see the Materials and methods section) to release the 'dense-vesicle' enzyme selectively from a crude membrane fraction as described by Loten et al. (1978) . On the basis of several criteria this enzyme has been shown to be that designated by us as the 'dense-vesicle' enzyme.
Cells were also preincubated with the lysosomotropic agents NH4C1 (10mM), chloroquine (0.2mM) and methylamine (10mM) for 15 min at 37 0C before exposure to insulin (10nM) for 5min. After such a treatment, insulin's activation of the 'dense-vesicle' enzyme, whether assessed directly by Percollgradient analysis or indirectly by hypo-osmotic release, was almost completely abolished. In contrast, insulin's activation of the plasma-membrane enzyme was essentially unchanged (Table 1) . A similar selective effect (Table 1) could be achieved by using fructose to deplete specifically the intracellular ATP concentration (Boyes et al., 1981) to about 40% of its native (control) value.
All activations for the enzymes are expressed relative to control incubations where no insulin was added. The lysosomotropic agents had no effect on the activity of the plasma-membrane enzyme in control gradients. Although NH4Cl had no effect on the 'dense-vesicle' enzyme in control gradients (99 + 3% of native), activity was decreased by either methylamine (78 + 5% of native) or chloroquine (63 + 3% of native; means + S.E.M., n = 3). However, at the concentrations used in the incubations, the addition of these agents directly to the membrane fraction, used for hypo-osmotic extraction, derived from control cells affected neither the extent of release of the enzyme by hypo-osmotic shock nor the total cyclic AMP phosphodiesterase activity displayed.
If the incubation of the hepatocytes with insulin was performed at 220C, rather than 37°C, then the activation of the 'dense-vesicle' enzyme was markedly decreased (<20% of that at 370C), whereas Table 1 . Effects of lysosomotropic agents, cellular A TP depletion and lowered temperature on the activation by insulin of hepatocvte 'dense-vesicle' and peripheral-plasma-membrane cyclic AMP phosphodiesterase Unless otherwise specified. incubations were performed at 370C as described in detail in the Materials and methods section. Experiments were performed with three different cell preparations (results are means + S.E.M.). Cells were preincubated as described in the Materials and methods section with ligands before exposure to insulin for 5min.
Activation of the 'dense-vesicle' enzyme was monitored either directly by Percoll-gradient analysis or indirectly by selective extraction by using hypo-osmotic shock.
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Rapid Papers the degree of activation of the plasma-membrane enzyme fell by only about one-half (Table 1) . Intracellular ATP concentrations were unaffected either by the lysosomotropic agents or by incubation at 22°C (Table 1) .
Before exposure of the cells to insulin (10nM) for 5min at 370C, incubation for 15min at 37°C with bacitracin (1 mM), p-tosyl-L-arginine methyl ester (2mM), a-N-benzoyl-L-arginine methyl ester (2mM), N-a-acetyl-L-lysine methyl ester (2 mM), soya-bean trypsin inhibitor (0.1 mg/ml) and leupeptin (0.1 mM) failed to exert any effect (< 10%) on insulin's activation of the 'dense-vesicle' enzyme. These experiments were performed by the hypo-osmoticshock release method, except for leupeptin, which was assessed by the Percoll-gradient procedure. This was because the hypo-osmotic-shock release of the 'dense-vesicle' enzyme was potently inhibited by leupeptin at the concentrations used. Leupeptin also failed to exert any inhibitory effect (< 10%) on insulin's activation of the plasma-membrane enzyme.
Discussion
Insulin exerts its effects on hepatocyte intracellular cyclic AMP concentrations by activating cyclic AMP phosphodiesterases (see, e.g., Houslay et al., 1983a,b; Heyworth et al., 1983a) and inhibiting adenylate cyclase (Heyworth & Houslay, 1983) . The activity of at least two distinct cyclic AMP phosphodiesterases is augmented by the exposure of hepatocytes to insulin. These highaffinity enzymes are associated with the plasma membrane and an internal 'dense-vesicle' fraction respectively (Heyworth et al., 1 983a) . Such enzymes have been used by us as probes to investigate the molecular action of insulin.
Here we see that depletion of intracellular ATP concentrations (confirming the observation by Boyes et al., 1981) , preincubation of hepatocytes with lysosomotropic agents, and lowering the incubation temperature to 220C, all blocked the activation by insulin of the 'dense-vesicle' cyclic AMP phosphodiesterase selectively (Table 1) . This supports our contention that insulin activates the dense-vesicle enzyme through a distinct route from that employed to activate the plasma-membrane enzyme.
Insulin binds to its receptors at the cell surface. Then, like a number of ligands, the receptor-insulin complex is recruited into coated pits Fan et al., 1982; Pilch et al., 1983) and internalized within minutes by receptor-mediated endocytosis into vesicle fractions Caro et al., 1982 ). The receptor complex may then be eventually degraded within the lysosomes or re-cycled back to the plasma membrane (Green & Olefsky, 1982; Fehlmann et al., 1982; Marshall et Vol. 216 al., 1981) . Lysosomotropic amines have been shown to block both the recycling of receptors to the plasma membrane and also lysosomal processing of the internalized insulin receptors (Marshall & Olefsky, 1979; Marshall et al., 1981; Draznin et al., 1981; Whittaker et al., 1981; Green & Olefsky, 1982; Posner et al., 1982) . Such studies demonstrated that, both in hepatocytes and in adipocytes, insulin internalization does occur in the presence of lysosomotropic amines, although the rate of internalization might well be decreased . Receptor-mediated endocytosis and so-called membrane processing/traffic phenomena are also both strongly inhibited upon ATP depletion of cells and by lowering the temperature to around 200C or below (Marshall & Olefsky, 1979; Carpentier et al., 1979; Draznin et al., 1981; Besterman & Low, 1983) . It is thus possible that insulin might activate the dense-vesicle enzyme through an event triggered by the intemalization and subsequent processing of the insulin-receptor complex. Certainly, insulin is known to cause the redistribution and activation of glucose-transporter molecules from an internalvesicle pool to the plasma membrane of adipocytes (Wardzala et al., 1978; Suzuki & Kono, 1980; Karnieli et al., 1981) . This process is also blocked upon ATP depletion and by lowering the incubation temperature (Siegel & Olefsky, 1980) . Applied to the 'dense-vesicle' enzyme, such a mechanism might be expected to involve the recruitment of a latent phosphodiesterase enzyme into the vesicle fraction, with subsequent activation, as insulin causes a net increase in cyclic AMP phosphodiesterase activity in hepatocytes . Furthermore, none of the expressed cyclic AMP phosphodiesterase activities associated with other subcellular membranes (Marchmont & Houslay, 1980a; Cercek & Houslay, 1982; Cercek et al., 1983) have characteristics similar to those of the integral 'dense-vesicle' enzyme.
We cannot exclude the possibility that a proteolytic event is involved with the activation of this enzyme. Certainly a number of phosphodiesterases are activated by limited proteolysis (see, e.g., Makino et al., 1982; . Indeed, Makino et al. (1982) have suggested that, in adipocytes, the phosphodiesterase corresponding to our 'dense-vesicle' enzyme might be activated by a thiol-dependent proteinase, which was specifically inhibited by leupeptin. However, although leupeptin is known to be taken up into hepatocytes, where it inhibits protein degradation (Grinde & Seglen, 1980) , it failed to block insulin's activation of the dense-vesicle enzyme (Table 1) . Furthermore, a variety of other proteinase inhibitors failed to exert any effect on insulin's activation of the 'densevesicle' enzyme, although we have not determined their accessibility to the cell interior. Chloroquine has been demonstrated to inhibit the rate of insulin degradation (Dennis & Aronson, 1981) , presumably by blocking endocytosis. In order to investigate the possibility that degradation of insulin at the cell surface or extracellularly was not involved in the activation of the 'dense-vesicle' enzyme, we added bacitracin to block this process (Carpentier et al., 1979) . Under the conditions of our experiment (10nM-insulin) bacitracin does not impair insulin's internalization (Carpentier et al., 1979) and was shown to exert no effect on insulin's activation of the 'dense-vesicle' enzyme. We thus consider a proteolytic event involved in the activation of the 'densevesicle' enzyme by insulin as unlikely, on the basis of the current evidence.
Activation of the plasma-membrane enzyme by insulin is known to involve phosphorylation by a membrane-bound kinase. This event can occur in broken membranes (Marchmont & Houslay, 1980b; Houslay et al., 1983a ) and therefore would not be expected to be affected by receptor internalization. Furthermore, the kinase involved expresses a Ka for MgATP of around 30pM , which would, again, not be affected by the magnitude of ATP depletion elicited in the present studies. The decrease in the degree of activation elicited on lowering the temperature to 220C (Table 1) is thus quite in accord with an enzyme-mediated phenomenon. Our present study thus provides further support for our contention that the activation of the plasma-membrane enzyme by insulin, which has been suggested to involve a specific species of guanine nucleotide regulatory protein (Heyworth et al., 1 983a,b) and associated protein kinase(s), occurs through a route distinct from that whereby insulin activates the 'dense-vesicle' enzyme.
